HRP20010845B1 - Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives - Google Patents

Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Info

Publication number
HRP20010845B1
HRP20010845B1 HR20010845A HRP20010845A HRP20010845B1 HR P20010845 B1 HRP20010845 B1 HR P20010845B1 HR 20010845 A HR20010845 A HR 20010845A HR P20010845 A HRP20010845 A HR P20010845A HR P20010845 B1 HRP20010845 B1 HR P20010845B1
Authority
HR
Croatia
Prior art keywords
alkyl
phenyl
group
substituted
halogen
Prior art date
Application number
HR20010845A
Other languages
English (en)
Croatian (hr)
Inventor
Heitsch Holger
Christian Englert Heinrich
Wirth Klaus
Goegelein Heinz
Original Assignee
Sanofi-Aventis Deutschland Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh
Publication of HRP20010845A2 publication Critical patent/HRP20010845A2/hr
Publication of HRP20010845A9 publication Critical patent/HRP20010845A9/xx
Publication of HRP20010845B1 publication Critical patent/HRP20010845B1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/02Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/53X and Y not being nitrogen atoms, e.g. N-sulfonylcarbamic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/50Compounds containing any of the groups, X being a hetero atom, Y being any atom
    • C07C311/52Y being a hetero atom
    • C07C311/54Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea
    • C07C311/57Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings
    • C07C311/58Y being a hetero atom either X or Y, but not both, being nitrogen atoms, e.g. N-sulfonylurea having sulfur atoms of the sulfonylurea groups bound to carbon atoms of six-membered aromatic rings having nitrogen atoms of the sulfonylurea groups bound to hydrogen atoms or to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/40Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of thiourea or isothiourea groups further bound to other hetero atoms
    • C07C335/42Sulfonylthioureas; Sulfonylisothioureas
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52Radicals substituted by nitrogen atoms not forming part of a nitro radical

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Vascular Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HR20010845A 1999-05-20 2001-11-16 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives HRP20010845B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19923086A DE19923086A1 (de) 1999-05-20 1999-05-20 Cinnamoylaminoalkyl-substituierte Benzolsulfonamidderivate, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
PCT/EP2000/004091 WO2000071513A1 (en) 1999-05-20 2000-05-06 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Publications (3)

Publication Number Publication Date
HRP20010845A2 HRP20010845A2 (en) 2003-04-30
HRP20010845A9 HRP20010845A9 (en) 2010-06-30
HRP20010845B1 true HRP20010845B1 (en) 2010-08-31

Family

ID=7908577

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20010845A HRP20010845B1 (en) 1999-05-20 2001-11-16 Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives

Country Status (30)

Country Link
US (1) US6350778B1 (da)
EP (1) EP1183236B1 (da)
JP (1) JP4559640B2 (da)
KR (1) KR100968729B1 (da)
CN (1) CN1243730C (da)
AR (1) AR035625A1 (da)
AT (1) ATE252554T1 (da)
AU (1) AU771675B2 (da)
BR (1) BR0010821B1 (da)
CA (1) CA2374226C (da)
CZ (1) CZ302943B6 (da)
DE (2) DE19923086A1 (da)
DK (1) DK1183236T3 (da)
EE (1) EE04611B1 (da)
ES (1) ES2208342T3 (da)
HK (1) HK1047574B (da)
HR (1) HRP20010845B1 (da)
HU (1) HU229041B1 (da)
IL (2) IL146372A0 (da)
ME (1) MEP41508A (da)
MX (1) MXPA01011725A (da)
NO (1) NO321558B1 (da)
PL (1) PL201560B1 (da)
PT (1) PT1183236E (da)
RS (1) RS50172B (da)
RU (1) RU2242462C2 (da)
SK (1) SK287237B6 (da)
TR (1) TR200103312T2 (da)
WO (1) WO2000071513A1 (da)
ZA (1) ZA200109481B (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10054482A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Heteroarylacryloylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
DE10054481A1 (de) 2000-11-03 2002-05-08 Aventis Pharma Gmbh Acylaminoalkyl-substituierte Benzolsulfonamidderivate, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate
CN1237185C (zh) * 2003-06-04 2006-01-18 中国科学院上海药物研究所 Sars冠状病毒3cl蛋白酶三维结构模型与抗sars药物

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1443878A1 (de) * 1963-10-19 1968-12-12 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518877A1 (de) * 1964-10-07 1969-01-30 Hoechst Ag Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1545810A1 (de) * 1965-05-06 1969-12-11 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
EP0612724A1 (de) * 1993-02-23 1994-08-31 Hoechst Aktiengesellschaft Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
EP0727416A1 (de) * 1995-02-17 1996-08-21 Hoechst Aktiengesellschaft Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1518816C3 (de) 1965-03-24 1975-05-22 Farbwerke Hoechst Ag, Vormals Meister Lucius & Bruening, 6000 Frankfurt Benzolsulfonylharnstoffe, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
US4066639A (en) 1965-05-06 1978-01-03 Hoechst Aktiengesellschaft Benzene-sulfonyl semicarbazides and process for preparing them
DE2413514C3 (de) * 1974-03-21 1982-03-04 Hoechst Ag, 6000 Frankfurt N-Acylaminoathylbenzolsulfonyl-N'-methylharnstoffe, Verfahren zu ihrer Herstellung und deren Verwendung
DE4341655A1 (de) 1993-12-07 1995-06-08 Hoechst Ag Aminosubstituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
JPH0826995A (ja) * 1994-07-22 1996-01-30 Nisshin Flour Milling Co Ltd ベンズイミダゾール誘導体を含有する抗不整脈剤
DE19832009A1 (de) 1998-07-16 2000-01-20 Hoechst Marion Roussel De Gmbh 2,5-Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung und sie enthaltende pharamazeutische Präparate
KR100981592B1 (ko) 1998-09-10 2010-09-13 사노피-아벤티스 도이칠란트 게엠베하 벤젠설포닐(티오)우레아 또는 베타-수용체 차단제와 배합된 벤젠설포닐(티오)우레아를 포함하는 자율신경계 기능부전의 치료 또는 예방을 위한 약제학적 조성물
US6303637B1 (en) * 1998-10-30 2001-10-16 Merck & Co., Inc. Heterocyclic potassium channel inhibitors
US6194458B1 (en) * 1998-10-30 2001-02-27 Merck & Co., Inc. Benzamide potassium channel inhibitors
US6632836B1 (en) * 1998-10-30 2003-10-14 Merck & Co., Inc. Carbocyclic potassium channel inhibitors

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1443878A1 (de) * 1963-10-19 1968-12-12 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylharnstoffen
DE1518877A1 (de) * 1964-10-07 1969-01-30 Hoechst Ag Benzolsulfonylharnstoffe und Verfahren zu ihrer Herstellung
DE1545810A1 (de) * 1965-05-06 1969-12-11 Hoechst Ag Verfahren zur Herstellung von Benzolsulfonylsemicarbaziden
EP0612724A1 (de) * 1993-02-23 1994-08-31 Hoechst Aktiengesellschaft Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe- Verfahren zu ihrer Herstellung und ihre Verwendung als Pharmazeutika
EP0727416A1 (de) * 1995-02-17 1996-08-21 Hoechst Aktiengesellschaft Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
PT1183236E (pt) 2004-03-31
HRP20010845A2 (en) 2003-04-30
EP1183236A1 (en) 2002-03-06
DE60006104T2 (de) 2004-08-05
DE19923086A1 (de) 2000-11-23
HUP0201906A3 (en) 2005-04-28
CZ302943B6 (cs) 2012-01-25
CA2374226C (en) 2010-08-31
EE200100609A (et) 2003-02-17
ATE252554T1 (de) 2003-11-15
CZ20014149A3 (cs) 2002-03-13
DK1183236T3 (da) 2004-02-23
YU81701A (sh) 2004-07-15
EP1183236B1 (en) 2003-10-22
HK1047574B (zh) 2006-08-04
AU5393300A (en) 2000-12-12
PL351751A1 (en) 2003-06-16
EE04611B1 (et) 2006-04-17
NO321558B1 (no) 2006-05-29
HK1047574A1 (en) 2003-02-28
CN1360571A (zh) 2002-07-24
IL146372A (en) 2007-05-15
MEP41508A (en) 2011-02-10
RS50172B (sr) 2009-05-06
HRP20010845A9 (en) 2010-06-30
PL201560B1 (pl) 2009-04-30
IL146372A0 (en) 2002-07-25
HU229041B1 (hu) 2013-07-29
HUP0201906A2 (en) 2002-09-28
RU2242462C2 (ru) 2004-12-20
NO20015636D0 (no) 2001-11-19
WO2000071513A1 (en) 2000-11-30
AR035625A1 (es) 2004-06-23
BR0010821A (pt) 2002-03-05
US6350778B1 (en) 2002-02-26
KR100968729B1 (ko) 2010-07-08
AU771675B2 (en) 2004-04-01
SK287237B6 (sk) 2010-04-07
CA2374226A1 (en) 2000-11-30
SK16692001A3 (sk) 2002-04-04
DE60006104D1 (de) 2003-11-27
MXPA01011725A (es) 2002-04-24
JP4559640B2 (ja) 2010-10-13
JP2003500388A (ja) 2003-01-07
ZA200109481B (en) 2002-06-25
NO20015636L (no) 2002-01-15
TR200103312T2 (tr) 2002-04-22
BR0010821B1 (pt) 2011-07-12
KR20020005046A (ko) 2002-01-16
ES2208342T3 (es) 2004-06-16
CN1243730C (zh) 2006-03-01

Similar Documents

Publication Publication Date Title
JO2791B1 (en) Acid secretion inhibitor
CA2616580A1 (en) Macrocyclic inhibitors of hepatitis c virus
AR080803A1 (es) Derivados de 3,4-dihidro-1h-benzo[b][1,6]naftiridina, composiciones farmaceuticas que los contiene, procedimiento para prepararlos e intermediarios del mismo, y uso de los compuestos en el tratamiento de canceres y enfermedades autoinmunes e inflamatorias.
RS52061B (en) PIRAZOLYL-AMINOPYRIDINE DERIVATIVES USEFUL AS KINASE INHIBITORS
MX2007008308A (es) Derivados de n-(heteroaril)-1h-indol-2-carboxamidas y su utilizacion como ligandos del receptor vaniloide trpv1-.
AR078833A1 (es) Derivados de heteroarilos que contienen nitrogeno como inhibidores dela cinasa jak3
BRPI0510335A (pt) composto heterocìclico
EA200970379A1 (ru) Бициклические гетероароматические соединения
EA200500822A1 (ru) Замещённый индолпиридиний в качестве противоинфекционных соединений
AR093725A1 (es) Quinazolincarboxamida azetidinas
AR068538A1 (es) Compuesto heterociclico de 5 miembros con actividad supresora de la secrecion de acido
WO2009041447A1 (ja) 5員複素環化合物
EA201070876A1 (ru) Трициклические соединения, обладающие антагонистической активностью по отношению к кортикотропин-высвобождающему фактору, и содержащие их фармацевтические композиции
HK1109771A1 (en) Thienopyridine derivatives as potassium channel inhibitors
DK0759027T3 (da) Bicykliske amidinderivater som inhibitorer af nitrogenoxidsynthetase
AR070291A1 (es) AZAINDOL-3-CARBOXAMIDAS CíCLICAS, SU PREPARACIoN, SU USO COMO PRODUCTOS FARMACÉUTICOS Y SU EMPLEO EN LA FABRICACIoN DE UN MEDICAMENTO PARA EL TRATAMIENTO DE ENFERMEDADES MEDIADAS POR LA MODULACIoN DE RAS.
HRP20010845B1 (en) Cinnamoylaminoalkyl-substituted benzenesulfonamide derivatives
RU2002114041A (ru) N-гуанидиноалкиламиды, их получение, их применение и содержащие их фармацевтические препараты
ATE246177T1 (de) Katecholhydrazon-derivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die diese enthalten
RU2015121347A (ru) Производные, содержащие циклическую сульфонамидную группу, в качестве ингибиторов сигнального пути hedgenog
RS51141B (sr) Supstituisani tiofeni, postupak za njihovu proizvodnju, njihova primena u svojstvu leka, kao i lek koji sadrži ova jedinjenja
RS54001B1 (en) SUBSTITUTED [(5H-Pyrrolo [2,1-C] [1,4] BENZODIAZEPIN-11-IL-) PIPERAZIN-1-IL] -2,2-DIMETHYLPROPANOIC ACID COMPOUNDS HT 2A
TH85621B (th) อนุพันธ์เฮเมอโรแอริลเอธินิล, การผลิตและการใช้ในฐานะตัวกระทำทางเภสัชกรรมของสารนั้น
RU2005140090A (ru) Способ синтеза гетероциклических соединений
TH88596B (th) สารประกอบเคมี

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
PNAN Change of the applicant name, address/residence

Owner name: SANOFI-AVENTIS DEUTSCHLAND GMBH, DE

A9IS Complete republication of an hr-a document
B1PR Patent granted
ODRP Renewal fee for the maintenance of a patent

Payment date: 20140411

Year of fee payment: 15

PBON Lapse due to non-payment of renewal fee

Effective date: 20150506